Literature DB >> 24007447

Research in the field of drug therapy safety management.

Horst Möller1, Amin-Farid Aly.   

Abstract

In August 2011, the Coordination Group for the implementation and continuation of the agenda for improving medication safety in Germany published a memorandum on the development of research in the field of drug therapy safety management (Memorandum on Drug Therapy Safety Management Research). The memorandum highlights the need for research into this field for the German health care system. It describes current research objectives, thematic priorities and the characteristics of the methodology of drug therapy safety management research. After presenting the current state of research into drug therapy safety management, suggestions are made regarding further necessary activities.
© 2013 The British Pharmacological Society.

Keywords:  drug safety; medication error; research

Mesh:

Year:  2013        PMID: 24007447      PMCID: PMC3781673          DOI: 10.1111/bcp.12200

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  5 in total

Review 1.  The effectiveness of Teratology Information Services (TIS).

Authors:  Rebecca L Hancock; Gideon Koren; Adrienne Einarson; Wendy J Ungar
Journal:  Reprod Toxicol       Date:  2006-11-18       Impact factor: 3.143

2.  [Definitions related to pharmacovigilance and drug safety].

Authors:  Horst Möller; Amin-Farid Aly
Journal:  Z Evid Fortbild Qual Gesundhwes       Date:  2012-11-22

3.  Temporal trends in rates of patient harm resulting from medical care.

Authors:  Christopher P Landrigan; Gareth J Parry; Catherine B Bones; Andrew D Hackbarth; Donald A Goldmann; Paul J Sharek
Journal:  N Engl J Med       Date:  2010-11-25       Impact factor: 91.245

4.  Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study.

Authors:  Sebastian Schneeweiss; Joerg Hasford; Martin Göttler; Annemarie Hoffmann; Ann-Kathrin Riethling; Jerry Avorn
Journal:  Eur J Clin Pharmacol       Date:  2002-06-12       Impact factor: 2.953

5.  Health care use and costs of adverse drug events emerging from outpatient treatment in Germany: a modelling approach.

Authors:  Renee G Stark; Jürgen John; Reiner Leidl
Journal:  BMC Health Serv Res       Date:  2011-01-13       Impact factor: 2.655

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.